Home › Funds › Aristotle Capital Boston, LLC › CRL

Aristotle Capital Boston, LLC position in CRL

CHARLES RIV LABS INTL INC · Health Care

Aristotle Capital Boston, LLC reported holding 80,574 shares of CRL (CHARLES RIV LABS INTL INC) in its Q2 2026 13F filing — a position valued at US$18.3M, representing 1.23% of its reported portfolio and ranking #31 among its reported holdings. Aristotle Capital Boston, LLC has disclosed CRL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)80.57K sh
Reported value held$18.27M
Portfolio Weight1.23%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Aristotle Capital Boston, LLC's CRL position evolved

Aristotle Capital Boston, LLC first disclosed a stake in CRL in Q3 2023 at 158,904 shares (US$31.1M). The position peaked in Q1 2024 at 148,579 shares, worth US$40.3M. Across 12 filings, Aristotle Capital Boston, LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 80,574 shares valued at US$18.3M — a reduction of -16,860 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 158.90K $31.14M New
Q4 2023 153.67K $36.33M Reduce
Q1 2024 148.58K $40.26M Reduce
Q2 2024 150.69K $31.13M Add
Q3 2024 144.71K $28.50M Reduce
Q4 2024 130.16K $24.03M Reduce
Q1 2025 104.48K $15.73M Reduce
Q2 2025 96.35K $14.62M Reduce
Q3 2025 95.35K $14.92M Reduce
Q4 2025 86.21K $17.20M Reduce
Q1 2026 97.43K $16.81M Add
Q2 2026 80.57K $18.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 30 other funds we track also report a position in CRL — the largest reported positions include Allspring Global Investments Holdings, LLC (US$436.5M), ARIEL INVESTMENTS, LLC (US$341.6M), EARNEST PARTNERS LLC (US$254.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has Aristotle Capital Boston, LLC held CRL?

Aristotle Capital Boston, LLC has disclosed CRL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Aristotle Capital Boston, LLC's current position in CRL?

As of Q2 2026, Aristotle Capital Boston, LLC holds 80.57K shares of CRL (CHARLES RIV LABS INTL INC), valued at $18.27M, representing 1.23% of its reported portfolio and ranking #31.

Has Aristotle Capital Boston, LLC been buying or selling CRL?

In the latest 13F filing (Q2 2026), Aristotle Capital Boston, LLC reduced its position in CRL. The position peaked in Q1 2024 at 148.58K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include Allspring Global Investments Holdings, LLC, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.